The Starling system is a 100% non-invasive fluid management monitoring system that provides clinicians with the confidence to respond to ever-changing patient status and dose IV fluids according to patient response. The Starling system offers an accurate, reliable and non-invasive method to measure flow at the patient’s core and deliver meaningful insights to guide clinical decision-making
Starling Fluid Management System
The Starling system is a 100% non-invasive fluid management monitoring system that provides clinicians with the confidence to respond to ever-changing patient status and dose IV fluids according to patient response. The Starling system offers an accurate, reliable and non-invasive method to measure flow at the patient’s core and deliver meaningful insights to guide clinical decision-making
Related products
-
Multicath 4 HFS
Multicath Quadra is a polyurethane intravenous catheter intended for use with the Seldinger technique (adult model). It has four paths (four lumens) totally separated throughout the entire length of the catheter. Each line leads, at a distal end of the catheter, into a different hole.
-
Camino® Intracraneal Pressure Monitor
The Camino ICP monitoring system is the most advanced platform to deliver multimodality neuromonitoring from Natus. Continuous monitoring allows for early intervention to potentially improve patient outcomes
-
Bowman Perfusion Monitoring System
The Bowman Perfusion Monitor® (BPM) (cat. #H0000-0710) is the most innovative technology of its kind. The BPM continuously quantifies tissue blood flow (perfusion) in real-time, in absolute physiological units of ml/100g-min.
-
Thermogard XP® TGXP Temperature Management
The Thermogard XP® (TGXP) temperature management system offers superior clinical efficiency in reaching and maintaining target temperature 100% of the time.1‑6 A variety of standard central venous catheters (CVCs) and unmatched control regardless of target temperature enable you to tailor the treatment to the individual.
Reviews
There are no reviews yet.